72 related articles for article (PubMed ID: 17426487)
1. Protection against Abeta-induced memory loss by tripeptide D-Arg-L-Glu-L-Arg.
Mileusnic R; Lancashire C; Clark J; Rose SP
Behav Pharmacol; 2007 May; 18(3):231-8. PubMed ID: 17426487
[TBL] [Abstract][Full Text] [Related]
2. The memory enhancing effect of the APP-derived tripeptide Ac-rER is mediated through CRMP2.
Mileusnic R; Rose SP
J Neurochem; 2011 Aug; 118(4):616-25. PubMed ID: 21255016
[TBL] [Abstract][Full Text] [Related]
3. The peptide sequence Arg-Glu-Arg, present in the amyloid precursor protein, protects against memory loss caused by A beta and acts as a cognitive enhancer.
Mileusnic R; Lancashire CL; Rose SP
Eur J Neurosci; 2004 Apr; 19(7):1933-8. PubMed ID: 15078567
[TBL] [Abstract][Full Text] [Related]
4. Amyloid precursor protein: from synaptic plasticity to Alzheimer's disease.
Mileusnic R; Lancashire CL; Rose SP
Ann N Y Acad Sci; 2005 Jun; 1048():149-65. PubMed ID: 16154929
[TBL] [Abstract][Full Text] [Related]
5. Protection against beta-amyloid peptide-induced memory impairment with long-term administration of extract of Angelica gigas or decursinol in mice.
Yan JJ; Kim DH; Moon YS; Jung JS; Ahn EM; Baek NI; Song DK
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):25-30. PubMed ID: 14687853
[TBL] [Abstract][Full Text] [Related]
6. Effects of beta-amyloid on behavioral and amino acids spectrum in rats' brain and their modulation by embryonic proteins.
Yenkoyan K; Safaryan K; Navasardyan G; Mkrtchyan L; Aghajanov M
Neurochem Int; 2009; 54(5-6):292-8. PubMed ID: 19121356
[TBL] [Abstract][Full Text] [Related]
7. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.
Jing W; Guo F; Cheng L; Zhang JF; Qi JS
Neurosci Lett; 2009 Feb; 450(3):306-10. PubMed ID: 19059464
[TBL] [Abstract][Full Text] [Related]
8. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
[TBL] [Abstract][Full Text] [Related]
9. Silibinin attenuates amyloid beta(25-35) peptide-induced memory impairments: implication of inducible nitric-oxide synthase and tumor necrosis factor-alpha in mice.
Lu P; Mamiya T; Lu LL; Mouri A; Niwa M; Hiramatsu M; Zou LB; Nagai T; Ikejima T; Nabeshima T
J Pharmacol Exp Ther; 2009 Oct; 331(1):319-26. PubMed ID: 19638571
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cytotoxicity and amyloid fibril formation by a D-amino acid peptide that specifically binds to Alzheimer's disease amyloid peptide.
Wiesehan K; Stöhr J; Nagel-Steger L; van Groen T; Riesner D; Willbold D
Protein Eng Des Sel; 2008 Apr; 21(4):241-6. PubMed ID: 18252750
[TBL] [Abstract][Full Text] [Related]
11. APP is required during an early phase of memory formation.
Mileusnic R; Lancashire CL; Johnston AN; Rose SP
Eur J Neurosci; 2000 Dec; 12(12):4487-95. PubMed ID: 11122359
[TBL] [Abstract][Full Text] [Related]
12. Acetyl-Ile-Gly-Leu protects neurons from Abeta(1-42) induced toxicity in vitro and in V337M human tau-expressing mice.
Xiong ZM; Kitagawa K; Nishiuchi Y; Kimura T; Nakamura T; Inagaki C
Life Sci; 2009 Jan; 84(5-6):132-8. PubMed ID: 19087881
[TBL] [Abstract][Full Text] [Related]
13. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation.
Song MS; Rauw G; Baker GB; Kar S
Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381
[TBL] [Abstract][Full Text] [Related]
14. The effects of chronic estradiol treatment on working memory deficits induced by combined infusion of beta-amyloid (1-42) and ibotenic acid.
Hruska Z; Dohanich GP
Horm Behav; 2007 Sep; 52(3):297-306. PubMed ID: 17583706
[TBL] [Abstract][Full Text] [Related]
15. Minocycline provides protection against beta-amyloid(25-35)-induced alterations of the somatostatin signaling pathway in the rat temporal cortex.
Burgos-Ramos E; Puebla-Jiménez L; Arilla-Ferreiro E
Neuroscience; 2008 Jul; 154(4):1458-66. PubMed ID: 18555616
[TBL] [Abstract][Full Text] [Related]
16. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease.
Prediger RD; Medeiros R; Pandolfo P; Duarte FS; Passos GF; Pesquero JB; Campos MM; Calixto JB; Takahashi RN
Neuroscience; 2008 Feb; 151(3):631-43. PubMed ID: 18191900
[TBL] [Abstract][Full Text] [Related]
17. Adenosine A2A receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by scopolamine or MK-801.
Cunha GM; Canas PM; Melo CS; Hockemeyer J; Müller CE; Oliveira CR; Cunha RA
Exp Neurol; 2008 Apr; 210(2):776-81. PubMed ID: 18191838
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
Rakover I; Arbel M; Solomon B
Neurodegener Dis; 2007; 4(5):392-402. PubMed ID: 17536186
[TBL] [Abstract][Full Text] [Related]
19. Effect on memory of acute administration of naturally secreted fibrils and synthetic amyloid-beta peptides in an invertebrate model.
Feld M; Galli C; Piccini A; Romano A
Neurobiol Learn Mem; 2008 May; 89(4):407-18. PubMed ID: 17920304
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of astrocytic energy metabolism by D-lactate exposure impairs memory.
Gibbs ME; Hertz L
Neurochem Int; 2008 May; 52(6):1012-8. PubMed ID: 18063442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
